38 Results

People

  1. Heller
    Heller
  2. Lesokhin
    Lesokhin
  3. Scheinberg
    Scheinberg
  4. Landgren
    Landgren
  5. Papaemmanuil
    Papaemmanuil
  6. Gonen
    Gonen
  7. Sadelain
    Sadelain
  8. Hsu
    Hsu
  9. O'Reilly
    O'Reilly
  10. Panageas
    Panageas

Groups

  1. Center for Hematologic Malignancies (38)
  2. Epidemiology and Biostatistics (38)
  3. Hematologic Malignancies Research (38)
  4. Department of Medicine (35)
  5. GSK Faculty (34)
  6. Biostatistics Service (32)
  7. Hematologic Malignancies, Division of (31)
  8. Sloan Kettering Institute Faculty (27)
  9. Tow Center for Developmental Oncology (TCDO) (25)
  10. Molecular Pharmacology and Chemistry Program Faculty (21)
  1. "controlled study"
  2. "Hematologic Malignancies Research"
  3. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (36)
  2. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (38)
  2. Epidemiology and Biostatistics (38)
  3. Hematologic Malignancies Research (38)
  4. Department of Medicine (35)
  5. GSK Faculty (34)
  6. Biostatistics Service (32)

More Groups

People
  1. Glenn Heller (12)
  2. Alexander Lesokhin (8)
  3. David Scheinberg (8)
  4. Carl Landgren (7)
  5. Elli Papaemmanuil (7)
  6. Michel Sadelain (6)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Blood (6)
  2. Nature Communications (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Blood Advances (2)
  5. Journal of Clinical Investigation (2)
  6. Journal of Immunology (2)

More Publications

Publishers
  1. Nature Publishing Group (11)
  2. American Society of Hematology (8)
  3. American Association for Cancer Research (2)
  4. American Society for Clinical Investigation (2)
  5. Elsevier Inc. (2)
  6. The American Association of Immunologists, Inc (2)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study
    Research Letter

    Castro, F.; Parikh, R.; Eustaquio, J. C.; Derkach, A.; Joseph, J. M.; Lesokhin, A. M.; Usmani, S. Z.; Shah, U. A.
    Leukemia (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Journal Article

    Erazo, T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Refermat, A. Y.; Asgari, Z.; Yang, X.; Da Silva Ferreira, M.; Mehta, S.; Russo, M. V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
    Journal Article

    Hasan, A. N.; Doubrovina, E.; Sottile, R.; Prockop, S.; Klatt, M. G.; Heller, G.; Selvakumar, A.; Barnett, L.; Hsu, K. C.; O’Reilly, R. J.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: A multicenter observational study
    Journal Article

    Khan, N.; Lindner, S.; Gomes, A. L. C.; Devlin, S. M.; Shah, G. L.; Sung, A. D.; Sauter, C. S.; Landau, H. J.; Dahi, P. B.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood
    Journal Article

    Fiala, E. M.; Ortiz, M. V.; Kennedy, J. A.; Glodzik, D.; Fleischut, M. H.; Duffy, K. A.; Hathaway, E. R.; Heaton, T.; Gerstle, J. T.; Steinherz, P.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
    Research Letter

    Maura, F.; Rustad, E. H.; Yellapantula, V.; Łuksza, M.; Hoyos, D.; Maclachlan, K. H.; Diamond, B. T.; Greenbaum, B. D.; Morgan, G.; Lesokhin, A.; more...
    Leukemia (2020)

    Fulltext@MSK | Save